Ergoteles LLC Guardant Health, Inc. Transaction History

Ergoteles LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$20.94 - $38.01 $2.34 Million - $4.24 Million	111,600 New	111,600 $4 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $331,816 - $463,600	7,600 New	7,600 $409,000
Q1 2022 May 13, 2022	SELL	$48.25 - $100.49 $581,412 - $1.21 Million	-12,050 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $1.07 Million - $1.45 Million	12,050 New	12,050 $1.21 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $4.66 Million - $6.23 Million	-47,135 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$109.77 - $165.68 $3.71 Million - $5.6 Million	33,779 Added 252.91%	47,135 $5.85 Million
Q1 2021 May 12, 2021	BUY	$127.04 - $179.1 $895,886 - $1.26 Million	7,052 Added 111.87%	13,356 $2.04 Million
Q4 2020 Feb 11, 2021	SELL	$99.96 - $135.93 $876,749 - $1.19 Million	-8,771 Reduced 58.18%	6,304 $812,000
Q3 2020 Nov 16, 2020	BUY	$80.32 - $111.8 $1.21 Million - $1.69 Million	15,075 New	15,075 $1.69 Million

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.51B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.